Phase 3 RCT of C5a-Specific Vilobelimab in Severe COVID-19 Pneumonia
A P Vlaar, G Hermans, M Witzenrath, P Van Paassen, L Heunks, B Mourvillier, S De Bruin, E L Lim, M Piagnerelli, A Roquilly, J Lascarrou, M Bauer, C Schwebel, M Brouwer, P Tuinman, T Welte, G Marx, U Jaschinski, A Cornet, A Grebenyuk, P Jorens, S Rückinger, K Pilz, C Thielert, D Neukirchen, L Ruckerbauer, B Burnett, R Guo, D Van De Beek, N Riedemann
European Respiratory Journal Sep 2022, 60 (suppl 66) 4725; DOI: 10.1183/13993003.congress-2022.4725